TCR Therapy Market – Engineered T-Cell Receptors Expanding Solid Tumor Immunotherapy
Market Overview The TCR therapy market is expanding as researchers develop engineered T-cell receptor therapies capable of recognizing intracellular tumor antigens that conventional CAR-T approaches cannot target. Unlike CAR-T cells, which recognize surface antigens, TCR-engineered T cells can detect peptide fragments presented via MHC molecules, opening therapeutic possibilities for solid...
0 Reacties 0 aandelen 8 Views 0 voorbeeld